A study conducted in Spain showed that single nucleotide polymorphisms (SNPs) in genes associated with atherogenic dyslipidemia, particularly the variants rs3135506 and rs662799 of the apolipoprotein-A5 (APOA5) gene, can influence the CD4 T-cell levels in chronic HIV-infected patients [107]. This evidence concerns the gene APOA5 and metabolic syndrome.